In the quest for sustainable development and prudent management of public resources, Ghana faces a critical juncture in reforming its public procurement landscape. While the Public Procurement ...
Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...
Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results